Anne Claxton

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida et al. · The Lancet Neurology · 2020 · 139 citations · Full text

Cerebrovascular Disease, Placebo-controlled Trial, Functional Outcome +19

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

Gillian Mead, Cheng‐Fang Hsieh, Rebecca Lee et al. · Sao Paulo Medical Journal · 2013 · 80 citations · Full text

Psychotropic Medication, Neurological Rehabilitation, Background Stroke +16

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial

John W. Eikelboom, Graeme J. Hankey, Jim Thom et al. · Journal of Thrombosis and Haemostasis · 2005 · 53 citations

Thrombosis, Cardiovascular Disease, Blood Platelet +7

Depression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery

Osvaldo P. Almeida, Graeme J. Hankey, Andrew H. Ford et al. · JAMA Neurology · 2021 · 21 citations · Full text

Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida et al. · Stroke · 2021 · 15 citations · Full text